Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
Public ClinicalTrials.gov record NCT01160601. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Phase 2 Trial of Paclitaxel/Carboplatin With or Without Bavituximab in Patients With Previously Untreated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Study identification
- NCT ID
- NCT01160601
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Peregrine Pharmaceuticals
- Industry
- Enrollment
- 86 participants
Conditions and interventions
Conditions
Interventions
- Paclitaxel / Carboplatin Drug
- bavituximab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2010
- Primary completion
- May 31, 2013
- Completion
- Aug 31, 2013
- Last update posted
- Apr 18, 2017
2010 – 2013
United States locations
- U.S. sites
- 17
- U.S. states
- 15
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ironwood Cancer and Research Center | Chandler | Arizona | 85224 | — |
| Baptist Clinical Research | Jonesboro | Arkansas | 72401 | — |
| American Institute of Research | Whittier | California | 90603 | — |
| Baptist Cancer Institute | Jacksonville | Florida | 32207 | — |
| Community Hospital | Munster | Indiana | 46321 | — |
| Cedar Valley Medical Specialists, PC | Waterloo | Iowa | 50701 | — |
| Southeast Nebraska Cancer Center | Lincoln | Nebraska | 68510 | — |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| The Center for Cancer and Hematologic Disease | Cherry Hill | New Jersey | 08003 | — |
| San Juan Oncology Associates | Farmington | New Mexico | 87401 | — |
| Presbyterian Hospital | Charlotte | North Carolina | 28204 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| The Christ Hospital Cancer Center Research | Cincinnati | Ohio | 45219 | — |
| Signal Point Clinical Research Center, LLC | Middletown | Ohio | 45042 | — |
| Gettysburg Cancer Center | Gettysburg | Pennsylvania | 17325 | — |
| Hematology-Oncology of Knoxville/Mercy Medical Center | Knoxville | Tennessee | 37909 | — |
| Delta Hematology Oncology Associates, PC | Portsmouth | Virginia | 23704 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01160601, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 18, 2017 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01160601 live on ClinicalTrials.gov.